Antibody Fragments Market Size

Antibody Fragments Market Size

The global antibody fragments market size was valued at around USD 7.3 billion in 2023 and is estimated to grow at a 5.6% CAGR from 2024 to 2032. Antibody fragments are smaller parts of full-length monoclonal antibodies, designed to retain the binding specificity of the parent antibody, but with unique properties that make them suitable for certain applications where full-length antibodies might not be as effective.

To get key market trends

  Download Free Sample

Rising demand for targeted therapies is driving revenue growth in the market. Growth in personalized medicine is contributing to an increasing demand for biologic therapies that are highly specific. Antibody fragments, known for their ability to be customized to interact with particular antigens, are emerging as prime candidates for these targeted therapies, especially in oncology and immunology.
 

For instance, as reported by China's National Medicines and Pharmaceutical Administration (NMPA), 2023 saw the approval of 87 novel drugs in China, with targeted therapies making up 67.8% of total approvals. The growth in targeted therapies is contributing to an increasing use of antibody fragments as therapeutics globally.
 

Additionally, the growing prevalence of cancer, advances in biotechnology and genetic engineering, and the increase in regulatory approvals are key factors contributing to market growth.